Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
- 13 April 2022
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 101 (6), 1282-1286
- https://doi.org/10.1016/j.kint.2022.04.009
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts General Hospital
- CareDx (2021A008053)
This publication has 7 references indexed in Scilit:
- A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipientsAmerican Journal of Transplantation, 2022
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serumThe Lancet, 2021
- SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionNature, 2021
- Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patientsScience Immunology, 2021
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsJAMA, 2021
- Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccineKidney International, 2021
- Is COVID-19 infection more severe in kidney transplant recipients?American Journal of Transplantation, 2020